These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3240811)

  • 1. [Cellular immunity in patients with Vogt-Koyanagi-Harada syndrome].
    Xie CF; Huang XK; Wen SD
    Yan Ke Xue Bao; 1988 Jun; 4(2):118-20. PubMed ID: 3240811
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis.
    Yokoyama MM; Matsui Y; Yamashiroya HM; O'Donnell MJ; Tseng CH; Snyder DA; Tessler HH; Crispen RG; Zimjewski CM
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):364-70. PubMed ID: 7203881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity to human myelin basic protein in Vogt-Koyahagi-Harada syndrome.
    Manor RS; Livni E; Cohen S
    Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):204-6. PubMed ID: 83972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular hypersensitivity to uveal pigment confirmed by leucocyte migration tests in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.
    Hammer H
    Br J Ophthalmol; 1974 Sep; 58(9):773-6. PubMed ID: 4473998
    [No Abstract]   [Full Text] [Related]  

  • 5. Surface markers of peripheral blood lymphocytes in Vogt-Koyanagi-Harada disease.
    Okubo K; Kurimoto S; Okubo K; Matsumoto K; Yokoyama MM
    J Clin Lab Immunol; 1985 May; 17(1):49-52. PubMed ID: 3840207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte subsets in peripheral blood and cerebrospinal fluid in Vogt-Koyanagi-Harada disease].
    Kuwasaki N; Shoji H; Kaji M; Matsumoto K; Yokoyama M
    Rinsho Shinkeigaku; 1985 Aug; 25(8):956-9. PubMed ID: 4064437
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological studies on lymphocytes in the cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease and sympathetic ophthalmia].
    Ariga H; Ohno S; Higuchi M; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1988 Feb; 92(2):225-8. PubMed ID: 3389270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Investigation of interferon system in Vogt-Koyanagi-Harada disease].
    Ohno S; Kotake S; Fjuii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1982; 86(10):1574-80. PubMed ID: 6187194
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunopathologic study of Vogt-Koyanagi-Harada syndrome.
    Chan CC; Palestine AG; Kuwabara T; Nussenblatt RB
    Am J Ophthalmol; 1988 Jun; 105(6):607-11. PubMed ID: 3259837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
    Zhao M; Jiang Y; Abrahams IW
    Arch Ophthalmol; 1991 Mar; 109(3):368-70. PubMed ID: 2003797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte transformation test in Vogt-Koyanagi-Harada syndrome (author's transl)].
    Momoeda S
    Nippon Ganka Gakkai Zasshi; 1976 Aug; 80(8):491-6. PubMed ID: 988721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphocyte transformation test and migration inhibition test of macrophages in Vogt-Koyanagi-Hirada's syndrome (author's transl)].
    Yuasa T; Murai Y; Hoki T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1973 Oct; 77(10):1652-7. PubMed ID: 4799026
    [No Abstract]   [Full Text] [Related]  

  • 13. [Existence of cytotoxic T lymphocytes specific for human melanoma cells in Vogt-Koyanagi-Harada disease (author's transl)].
    Maezawa N
    Nippon Ganka Gakkai Zasshi; 1981 Sep; 85(9):1406-11. PubMed ID: 6976680
    [No Abstract]   [Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada syndrome--isolation of cloned T cells with specificity for melanocytes and melanoma cells.
    McClellan KA; MacDonald M; Hersey P; Billson FA
    Aust N Z J Ophthalmol; 1989 Nov; 17(4):347-52. PubMed ID: 2624724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The association between major histocompatibility antigens (HLA) and Vogt-Koyanagi-Harada syndrome (author's transl)].
    Tagawa Y; Sugiura S; Yakura H; Wakisaka A; Aizawa M
    Nippon Ganka Gakkai Zasshi; 1976 Aug; 80(8):486-90. PubMed ID: 988720
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibody-dependent cell-mediated cytotoxicity (ADCC) against melanocyte antigens in Vogt-Koyanagi-Harada disease (author's transl)].
    Tagawa Y; Sugiura S
    Nippon Ganka Gakkai Zasshi; 1977 Aug; 81(8):1101-4. PubMed ID: 930771
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)].
    Sugiura S
    Nippon Ganka Gakkai Zasshi; 1976 Nov; 80(11):1285-326. PubMed ID: 1034425
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: HLA and Vogt-Koyanagi-Harada syndrome.
    Tagawa Y; Sugiura S; Yakura H; Wakisaka A; Aizawa M
    N Engl J Med; 1976 Jul; 295(3):173. PubMed ID: 1272341
    [No Abstract]   [Full Text] [Related]  

  • 19. [Involvement of Ia-positive accessory cells for activation of cytotoxic T lymphocyte specific for melanocyte-associated antigens in patients with Vogt-Koyanagi-Harada disease].
    Maezawa N; Tsukahara S
    Nippon Ganka Gakkai Zasshi; 1985 Mar; 89(3):440-6. PubMed ID: 3874531
    [No Abstract]   [Full Text] [Related]  

  • 20. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.